Literature DB >> 1253127

The histopathologic basis for functional decrements in late radiation injury in diverse organs.

D C White.   

Abstract

As more and more patients respond favorably to combined cancer therapies, the time of survival from radiotherapy will become the most important single factor in the incidence and progression of late radiation changes. The late sequelae of irradiation are the sum of the following: 1) residua of the direct and indirect early changes in responsive cell populations; 2) progressive vascular sclerosis with its associated effect upon connective tissue and the parenchymal cells; and 3) the reactive or replacement connective tissue proliferation which is responding to 1) and 2). From this it may be seen that further investigative efforts need direction toward: 1) reducing the magnitude and permanence of the early principal parenchymal cell injury; 2) diminishing the severity of the early microvascular change which adds significantly to the early parenchymal cell damage; 3) determining the mechanics of the progressive vascular sclerosis with a view to retarding this effect; and 4) lessening the reactive fibrosis.

Entities:  

Mesh:

Year:  1976        PMID: 1253127     DOI: 10.1002/1097-0142(197602)37:2+<1126::aid-cncr2820370823>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Comparison of the effects of melatonin and genistein on radiation-induced nephrotoxicity: Results of an experimental study.

Authors:  Emine Canyilmaz; Gonca Hanedan Uslu; Zumrut Bahat; Mustafa Kandaz; Sevdegul Mungan; Emel Haciislamoglu; Ahmet Mentese; Adnan Yoney
Journal:  Biomed Rep       Date:  2015-11-24

2.  Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.

Authors:  Arwa Nada; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2021-09-06       Impact factor: 3.651

3.  Accumulation of isolevuglandin-modified protein in normal and fibrotic lung.

Authors:  Stacey Mont; Sean S Davies; L Jackson Roberts Second; Raymond L Mernaugh; W Hayes McDonald; Brahm H Segal; William Zackert; Jonathan A Kropski; Timothy S Blackwell; Konjeti R Sekhar; James J Galligan; Pierre P Massion; Lawrence J Marnett; Elizabeth L Travis; Michael L Freeman
Journal:  Sci Rep       Date:  2016-04-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.